The association between serum lipids profile and HbA۱c in type ۲ diabetes mellitus in Tehran, Iran

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 250

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_INJER-4-2_006

تاریخ نمایه سازی: 22 خرداد 1400

Abstract:

Background and aims: Dyslipidemia is one of the major factors implicated in the development of the vascular complications of diabetes. In this study, it was evaluated the association between serum lipids profile and Hemoglobin A۱c (HbA۱c) in type ۲ diabetes mellitus. Methods: In this cross-sectional study, the serum lipid profile and HbA۱c was studied on ۵۶۲ Iranian patients who were older than ۳۰ years and had type ۲ diabetes identified from the diabetes and metabolic diseases clinic of endocrinology and metabolism research institute. A Multiple Linear Regression analysis was also done with the HbA۱c as outcome variable and serum lipids profile as predictor variables; adjusted for potential confounders (age, sex, diabetes duration and Body Mass Index (BMI)). Results: In ۱۹۶۶, ۶.۳۴% of the national total population was over ۶۰ years compared to mean age of the participants that was ۶۱.۶±۱۰.۴ years, with a range of ۳۲ to ۸۹ years. The results confirmed that the Triglyceride (TG) (β: ۰.۱۱, ۹۵% CI: ۰.۰۰۰-۰.۰۰۴, P=۰.۰۱) and cholesterol (β: ۰.۱۳, ۹۵% CI: ۰.۰۰۰-۰.۰۰۹, P=۰.۰۴) were correlated with the HbA۱c value but there were no significant association between HDL and LDL. Conclusion: This study demonstrated that in persons with type ۲ Diabetes Mellitus (DM), HbA۱c value is a good predictor of lipid profile. Therefore, lipid profiling for all persons with type ۲ DM should be a routine test.

Authors

Fatemeh Mehravar

Clinical Research Development Unit (CRDU), ۵ Azar Hospital, Golestan University of Medical Sciences, Gorgan, I.R. Iran

Mohammad Ali Mansournia

Epidemiology and Biostatistics Dept., Tehran University of Medical Sciences, Tehran, I.R. Iran

Moussa Abolhassani

Student Research Committee, Shahroud University of Medical Sciences, Shahroud, I.R. Iran

Kourosh Holakouie-Naieni

Epidemiology and Biostatistics Dept., Tehran University of Medical Sciences, Tehran, I.R. Iran

Ensie Nasli-Esfahani

Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, I.R. Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Krug EG. Trends in diabetes: Sounding the alarm. Lancet. ۲۰۱۶; ...
  • Mathers CD, Loncar D. Projections of global mortality and burden ...
  • Anderson TJ, Gregoire J, Hegele RA, Couture P, Mancini GB, ...
  • Mooradian AD. Dyslipidemia in type ۲ diabetes mellitus. Nat Clin ...
  • Durrington P. Dyslipidaemia. Lancet. ۲۰۰۳; ۳۶۲(۹۳۸۵): ۷۱۷-۳۱ ...
  • Krauss RM. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler ...
  • Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. ...
  • Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship ...
  • Siegel RD, Cupples A, Schaefer EJ, Wilson PW. Lipoproteins, apolipoproteins, ...
  • Krauss RM. Lipids and lipoproteins in patients with type ۲ ...
  • Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the ...
  • Saudek CD, Kalyani RR, Derr RL. Assessment of glycemia in ...
  • Pradhan AD, Rifai N, Buring JE, Ridker PM. Hemoglobin A۱c ...
  • Vaag AA. Glycemic control and prevention of microvascular and macrovascular ...
  • Ito C, Maeda R, Ishida S, Sasaki H, Harada H. ...
  • Doruk H, Mas MR, Ateskan U, Isik AT, Saglam M, ...
  • Morton J, Zoungas S, Li Q, Patel AA, Chalmers J, ...
  • Erciyas F, Taneli F, Arslan B, Uslu Y. Glycemic control, ...
  • Andersen G, Christiansen J, Mortensen H, Christiansen K, Predersen-Bjerguard L, ...
  • Ohta T, Nishiyama S, Nakamura T, Saku K, Maung KK, ...
  • Ko GT, Chan JC, Woo J, Lau E, Yeung VT, ...
  • Ladeia AM, Adan L, Couto Silva AC, Hiltner A, Guimaraes ...
  • Faulkner MS, Chao WH, Kamath SK, Quinn L, Fritschi C, ...
  • Grant T, Soriano Y, Marantz PR, Nelson I, Williams E, ...
  • Chan WB, Tong PC, Chow CC, So WY, Ng MC, ...
  • Khan HA, Sobki SH, Khan SA. Association between glycaemic control ...
  • Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. ...
  • Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. ...
  • Gu K, Cowie CC, Harris MI. Diabetes and decline in ...
  • Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E ...
  • Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, ...
  • Windler E. What is the consequence of an abnormal lipid ...
  • Freedman BI, Hsu FC, Langefeld CD, Rich SS, Herrington DM, ...
  • Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR. ...
  • Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, ...
  • نمایش کامل مراجع